Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 13,250 | 14,544 | 13,459 | 10,698 | 17,083 |
| Cost of Goods | 1,594 | 1,774 | 1,944 | 1,262 | 1,230 |
| Gross Profit | 11,656 | 12,770 | 11,515 | 9,436 | 15,853 |
| Operating Expenses | 82,011 | 82,242 | 80,100 | 73,615 | 66,659 |
| Operating Income | -69,761 | -68,698 | -67,641 | -63,917 | -50,576 |
| Interest Expense | 2,833 | 3,002 | 3,016 | 2,984 | 3,106 |
| Other Income | 7,940 | 2,282 | 2,843 | 2,848 | 5,294 |
| Pre-tax Income | -64,654 | -69,418 | -67,814 | -64,053 | -48,388 |
| Net Income Continuous | -64,654 | -69,418 | -67,814 | -64,053 | -48,388 |
| Net Income | $-64,654 | $-69,418 | $-67,814 | $-64,053 | $-48,388 |
| EPS Basic Total Ops | -0.27 | -0.38 | -0.39 | -0.38 | -0.25 |
| EPS Basic Continuous Ops | -0.27 | -0.38 | -0.39 | -0.38 | -0.25 |
| EPS Diluted Total Ops | -0.27 | -0.38 | -0.39 | -0.38 | -0.25 |
| EPS Diluted Continuous Ops | -0.27 | -0.38 | -0.39 | -0.38 | -0.25 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.37 | -0.39 | -0.37 | -0.29 |
| EBITDA(a) | $-68,514 | $-67,629 | $-66,615 | $-62,936 | $-49,625 |